ammonium chloride has been researched along with African Lymphoma in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (80.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Goldenberg, DM; Lu, HH; Shih, LB; Xuan, H | 1 |
| Dörken, B; May, RD; Moldenhauer, G; Vitetta, ES | 1 |
| Salord, J; Schuber, F | 1 |
| Bast, RC; Bregni, M; De Fabritiis, P; Greenberger, J; Lipton, J; Nadler, L; Raso, V; Ritz, J; Rothstein, L | 1 |
| Fulton, RJ; Uhr, JW; Vitetta, ES | 1 |
5 other study(ies) available for ammonium chloride and African Lymphoma
| Article | Year |
|---|---|
Internalization and intracellular processing of an anti-B-cell lymphoma monoclonal antibody, LL2.
Topics: 4-Chloro-7-nitrobenzofurazan; Ammonium Chloride; Antibodies, Monoclonal; Burkitt Lymphoma; Ceramides; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Golgi Apparatus; Humans; Immunoglobulin Fab Fragments; Kinetics; Leupeptins; Lymphoma, B-Cell; Lysosomes; Microscopy, Fluorescence; Tumor Cells, Cultured | 1994 |
Selective killing of normal and neoplastic human B cells with anti-CD19- and anti-CD22-ricin A chain immunotoxins.
Topics: Ammonium Chloride; Antigens, CD19; Antigens, Differentiation, B-Lymphocyte; Antigens, Surface; B-Lymphocytes; Burkitt Lymphoma; Cell Survival; Humans; Immunotoxins; Ricin; T-Lymphocytes; Temperature; Time Factors | 1986 |
In vitro drug delivery mediated by ecto-NAD+-glycohydrolase ligand-targeted liposomes.
Topics: Ammonium Chloride; Animals; Antineoplastic Agents; Burkitt Lymphoma; Cell Division; Cell Line; Deoxyuridine; Drug Carriers; Fibroblasts; Humans; Kinetics; Liposomes; Methotrexate; Mice; N-Glycosyl Hydrolases; NAD; NAD+ Nucleosidase; Sulfhydryl Compounds; Tumor Cells, Cultured | 1988 |
Elimination of clonogenic tumor cells from human bone marrow using a combination of monoclonal antibody:ricin A chain conjugates.
Topics: Ammonium Chloride; Antibodies, Monoclonal; Antigens, Neoplasm; Bone Marrow Cells; Bone Marrow Transplantation; Burkitt Lymphoma; Cell Line; Cell Survival; Colony-Forming Units Assay; Complement System Proteins; Dose-Response Relationship, Drug; Hematopoietic Stem Cells; Histocompatibility Antigens Class II; Humans; Immunotherapy; In Vitro Techniques; Neoplastic Stem Cells; Receptors, Antigen, B-Cell; Ricin | 1986 |
The effect of antibody valency and lysosomotropic amines on the synergy between ricin A chain- and ricin B chain-containing immunotoxins.
Topics: Adjuvants, Immunologic; Ammonium Chloride; Animals; Antibody Specificity; Antineoplastic Agents; Binding Sites, Antibody; Burkitt Lymphoma; Cell Line; Clone Cells; Cytotoxicity, Immunologic; Drug Synergism; Humans; Immunoglobulin Fab Fragments; Immunoglobulin G; Lysosomes; Mice; Mice, Inbred BALB C; Ricin | 1986 |